Takao Tsuneki, Takeru Matsuda, Ryuichiro Sawada, Hiroshi Hasegawa, Kimihiro Yamashita, Yasufumi Koterazawa, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, et al. Clinical significance of the maximum standardized uptake value on positron emission tomography to predict treatment response and outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy. Surgery Today. 2024
Naoto Shirakami, Shingo Kanaji, Atsushi Shimada, Tomosuke Mukoyama, Ryuichiro Sawada, Hitoshi Harada, Tomonori Tanaka, Naoki Urakawa, Hironobu Goto, Hiroshi Hasegawa, et al. Minimally invasive elective gastrectomy after preoperative chemotherapy in a patient with frailty who presented with locally far advanced-stage gastric cancer: a case report. Surgical Case Reports. 2024. 10. 1
Shingo Kanaji, Naoki Urakawa, Hitoshi Harada, Atsushi Shimada, Yasufumi Koterazawa, Ryuichiro Sawada, Hironobu Goto, Hiroshi Hasegawa, Kimihiro Yamashita, Takeru Matsuda, et al. Open left diaphragm method enables safe surgery with a good visual field in a laparoscopic transhiatal approach for esophagogastric junction adenocarcinoma laparoscopic transhiatal reconstruction via an open left diaphragm method. Langenbeck's Archives of Surgery. 2024. 409. 1
Yasufumi Koterazawa, Hironobu Goto, Hiroshi Saiga, Takashi Kato, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, et al. The number of resected lymph nodes from the upper mediastinal area predicts long-term outcomes of esophageal squamous cell carcinoma after minimally invasive esophagectomy. Surgical Endoscopy. 2024. 38. 7. 3625-3635
Hironobu Goto, Taro Oshikiri, Takashi Kato, Yoshiaki Nagatani, Yohei Funakoshi, Yasufumi Koterazawa, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, et al. Protocol for a phase II study to evaluate the efficacy and safety of nivolumab as a postoperative adjuvant therapy for patients with esophageal cancer treated with preoperative docetaxel, cisplatin plus 5-fluorouracil treatment (PENTAGON trial). PLOS ONE. 2024. 19. 4. e0299742-e0299742
